Timeliness and actionable intelligence over I-Banks research which remains only geared to institutional investors and legacy processes. News carries with it a promise of transparency, a light that can be shined into previously dark corners.
But they don’t define any relevance to the actual value of a release - mostly due to SEC forward looking parameters. However, this news portal has been expanded to … supplement, measure and price the event and relevance to a company’s ... valuation.
February 21, 2021
It Will Take The G-7 To Stop Covid-19: Here Are 5 Reasons Why
February 17, 2021
Caladrius Biosciences (CLBS) closes $65 M RDO (registered direct offering)
February 9, 2021
Biostage (BSTG): the questions linger … for there are never any answers from the company?
February 2, 2021
Pluristem (PSTI) proposes 4.76 M Registered Direct Offering (RDO) priced at $6.30
January 28, 2021
Bellicum Pharmaceuticals (BLCM) FDA has lifted the clinical hold
January 28, 2021
Applied Genetic Technologies (AGTC) prices 16.741 M share offering and warrants at $4.45
January 26, 2021
Precigen (PGEN) closes 17.25 M share offering at $7.50
January 25, 2021
Caladrius Biosciences (CLBS) closes $25 M Private Placement of 12.5 M shares plus warrants at a purchase price of $2.00
January 19, 2021
Editas Medicine (EDIT) proposes 3.5 million shares offering
January 12, 2021
REGENXBIO (RGNX) closes 4.26 million share offering at $47.00
January 6, 2021
Fate Therapeutics (FATE) prices 4.42 million share offering at $85.50 per share
December 24, 2020
Happy Hanukkah and a Merry Christmas as the NEW Year 2021 approaches
December 15, 2020
Cellectis S.A. (CLLS) cancels $100 M ADS (American Depositary Shares) offering
December 11, 2020
Solid Biosciences (SLDB) executes a $90 M Private Placement
December 2, 2020
Intellia Therapeutics (NTLA) prices 4.79 million share offering at $36.50
November 4, 2020
Bellicum Pharmaceuticals (BLCM) closes 1.04 M share offering
August 12, 2020
Adverum Biotechnologies (ADVM) closes $216.8 million offering priced at $3.00
July 8, 2020
BioLife Solutions (BLFS) closes 5.95 million share offering priced at $14.50
June 26, 2020
Editas Medicine (EDIT) closes 6.9 million shares offering at $31.25
June 11, 2020
Fate Therapeutics (FATE) completes 7,108 M share offering at $28.31 for proceeds of $201.3 million
June 6, 2020
Intellia Therapeutics (NTLA) closes $115 million offering
May 30, 2020
RegMed/Cell and Gene Therapy Earnings Scorecard - Q1/20 - to date
May 26, 2020
Caladrius Biosciences, Inc. (CLBS) closes RDO (registered direct offering) of 2.084 million shares priced at $2.06
May 25, 2020
Memorial Day - remember those we celebrate
May 19, 2020
bluebird bio (BLUE) proposes 9.09 M share offering priced at $55.00
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors